Modes and duration
- Part-time: 2 years (1 day per week)
Tuition Fees (2015/16)
- £5,560 (PT)
- £12,205 (PT)
- All applicants:
- 31 July 2015
A minimum of an upper second-class UK Bachelor’s degree in a relevant discipline or an equivalent overseas qualification, or an appropriate professional qualification or relevant work experience.
English Language Requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
Students learn about the science behind cell and tissue engineering as well as the historical context, and receive practical tuition in production of advanced therapy medicinal products (ATMPs) to EU good manufacturing practice (GMP) standards. They will develop skills to assist in ATMP development and validation whilst understanding the complex nature of clinical-grade cell and tissue manufacturing.
Students undertake modules to the value of 180 credits.
The programme consists of eight core modules (120 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, part-time 20 months) is offered.
A Postgraduate Certificate (60 credits, part-time 27 weeks) is offered.
- Basic Laboratory Methodology used in the Manufacture of ATMPs
- Commercialisation of ATMPs and the Role of Qualified Persons in ATMP Supply
- Designing and Commissioning a GMP Facility for ATMP Manufacture
- Development of Cell and Tissue Therapies and Clinical Trials of ATMPs
- Foundation of Cell and Tissue Therapies
- Quality and Validation in ATMP Manufacturing and Development
- The Clinical Application of Cell and Gene Therapies and Tissue Engineered Products
- The Global Regulation of Advanced Cell, Gene and Tissue Therapies
- There are no optional modules for this programme.
All students undertake an independent research project and are assessed by a written dissertation of 10,000-12,000 words and an oral presentation about their research project.
Teaching and Learning
The programme is delivered through a combination of lectures, discussion groups, and activities. Assessment is through coursework, laboratory practicals, presentations, examinations and the dissertation.
Scholarships relevant to this department are displayed below. For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
- £5,000 (1 year)
- Overseas students
- Based on academic merit
More scholarships are listed on the Scholarships and Funding website
The programme will benefit those planning to work or who are already working in an industrial or healthcare setting, particularly in the biopharmaceutical industry or the blood and tissue services sector. It will also be useful for those contemplating a PhD or medical studies.
Students acquire specific skill sets depending upon background knowledge and career choice, and a substantial research project element develops independent research skills whilst obtaining technical supervision and training.
Why study this degree at UCL?
The importance of advanced therapy medicinal products (ATMPs) in world healthcare is recognised by national governments in developed and developing countries.
UCL is a world-leading institution in both pre-clinical research and the clinical scale manufacture of ATMPs, which includes cell therapies, gene therapies and tissue engineered products (TEPs).
As an internationally recognised research and development centre, UCL has a more diverse range of ATMPs in clinical trial than any other academic centre in the world. Three UCL-developed ATMPs have already passed into commercialisation, demonstrating our ability to bridge the development gap between early trials and industry technology transfer.
Student / staff ratios › 350 staff › 38 taught students › 76 research students
Department: Cancer Institute
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
The programme is designed for life sciences graduates; scientists, clinicians, and other healthcare professionals, and especially individuals from the pharmaceutical and biotech industries. The programme is suitable for recent graduates as well as those who are in employment and seeking career development.
- All applicants
For more information see our Applications page.Apply now
What are we looking for?When we assess your application we would like to learn:
- why you want to study in this area at graduate level
- what particularly attracts you to the chosen programme
- how your personal, academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree